PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 10:00 AM ET

Sponsor Check › Person

MS
No photo found yet (own website and image search run after this page is viewed)

Mina Sooch

Named as an officer, director or promoter on SEC Form D filings · MI, NJ · Apr 4, 2012 → Nov 20, 2020

7deals (issuers)
$172.3Mreported sold
280investors
31Form D filings
2012–2020years on file
Follow this personLook further ↓PDF

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:18 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

Mina Sooch is listed as an executive officer, director, and promoter on 31 SEC Form D filings by 7 issuers between Apr 2009 and Nov 2020. Largest by amount reported sold: ProNAi Therapeutics Inc (Plymouth, MI — biotechnology — 2009–2014; $59.5M reported sold to 57 investors), SVELTE MEDICAL SYSTEMS INC (New Providence, NJ — biotechnology — 2009–2013; $50.4M reported sold to 39 investors), Opus Genetics, Inc. (Farmington Hills, MI — biotechnology — 2020; $25.8M reported sold to 18 investors), MetaVia Inc. (Cambridge, MA — biotechnology — 2015–2017; $17M reported sold to 59 investors), SeaStar Medical, Inc. (Denver, CO — other health care — 2009–2010; $16.4M reported sold to 23 investors) and 2 more (all listed below).

What this means A repeat sponsor — 7 separate companies raised money with this person listed as executive officer, director, and promoter, over about 11 years. Across those companies the filings report $172.3M sold in total.

Listed alongside Charles Bisgaier (13 shared filings), David R. Fischell (9 shared filings), Mark Pomeranz (9 shared filings), Phillip D. Torrence (9 shared filings), Robert E. Fischell (9 shared filings) and 50 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Mina. Each name links to their own page.

The issuers belong to 3 sponsor groups: Opus (2 issuers, $27.9M reported sold, 2018–2024), Seastar Medical (2 issuers, $8.57M reported sold, 2009–2026) and Group linked by Donald R. Parfet (6 issuers, $5.47M reported sold, 2009–2017).

What this means This person is listed across more than one sponsor team; each group page shows that team's full track record.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CO, CT, DC, DE, FINRA, FL, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VT, WA, WI, WV, WY) — none found.

What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.

We compared 31 public filings for Mina Sooch and found 25 differences, 5 worth asking the sponsor about: Amount sold went down between filings; Investor count went down between filings; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for Mina Sooch has not run yet — it is joining a line of 44,944 names; searches run around the clock at the hosts' allowed rate. Searched so far: 641 names.

Community comments are quoted as written by their authors. Sources searched: Bing (site:reddit.com / site:biggerpockets.com) and Reddit's own search, plus DuckDuckGo/Brave/BiggerPockets search when they are answering.

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

None found in sources searched — federal courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:18 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: 48 regulators (FINRA, NASAA, 37 states) — crawled Oct 24, 2026, 8:48 AM ET

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Mina Sooch..

State securities regulators: Securities regulators searched (64,910 actions): FINRA (38,350 actions, 1995–2026), NASAA (31 actions, 2000–2026; listing starts 1997), AK Division of Banking and Securities (273 actions, 1971–2025), AL Securities Commission (880 actions, 2001–2026), AR Securities Department (1,305 actions, 1998–2026), AZ Corporation Commission Securities Division (411 actions, 2017–2026), CA DFPI (25 actions, 2007–2024; listing starts 2002 — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), CO Division of Securities (731 actions, 2001–2026; older years from the Internet Archive (snapshot of 2026-05-02)), CT Department of Banking Securities Division (940 actions, 2006–2026; older years from the Internet Archive (snapshot of 2026-04-22)), DC DISB Securities Bureau (25 actions, 2012–2026), DE DOJ Investor Protection Unit (257 actions, 1987–2026), FL Office of Financial Regulation (49 actions, 2018–2026), GA Secretary of State Securities Division (65 actions, 2015–2026; listing starts 2012), HI DCCA Securities Enforcement Branch (26 actions, 2012–2026), ID Department of Finance Securities Bureau (663 actions, 1994–2026), IL Secretary of State Securities Department (4,122 actions, 2003–2023), KS Insurance Department Securities Division (58 actions), KY Department of Financial Institutions (342 actions, 2005–2026), LA Office of Financial Institutions Securities Division (13 actions, 2010–2025; listing starts 2008), MA Secretary of the Commonwealth Securities Division (125 actions, 2012–2025; live site blocks automated access — loaded from the Internet Archive snapshot of 2026-02-04), MD Attorney General Securities Division (1,054 actions, 2004–2026), ME Office of Securities (539 actions, 2000–2026), MI LARA Corporations, Securities & Commercial Licensing Bureau (201 actions), MO Secretary of State Securities Division (919 actions, 1998–2026), MS Secretary of State Securities Division (209 actions, 1995–2026), MT Commissioner of Securities and Insurance (597 actions, 2000–2026), NC Secretary of State Securities Division (265 actions, 2004–2024), ND Securities Department (711 actions, 1990–2026; the regulator no longer publishes this list live — loaded from the Internet Archive snapshot of 2026-01-06), NH Bureau of Securities Regulation (402 actions, 2002–2026), NM Regulation and Licensing Department Securities Division (90 actions, 2010–2025), NV Secretary of State Securities Division (118 actions, 2018–2026), NY Attorney General Investor Protection Bureau (44 actions, 2012–2026), OH Division of Securities (327 actions, 1993–2006), OK Department of Securities (2,531 actions, 1998–2026), OR Division of Financial Regulation (589 actions, 1988–2026), PA Department of Banking and Securities (1,448 actions, 2008–2024; the regulator no longer publishes this list live — loaded from the Internet Archive snapshot of 2024-08-09), RI DBR Securities Division (98 actions, 2005–2025), SC Attorney General Securities Division (540 actions, 2006–2026), SD Division of Insurance – Securities Regulation (106 actions, 2017–2026), TN Department of Commerce and Insurance Securities Division (405 actions, 1992–2026), TX State Securities Board (936 actions, 1999–2026), UT Division of Securities (772 actions, 2000–2026; older years from the Internet Archive (snapshot of 2010-05-27)), VT DFR Securities Division (137 actions, 2010–2026), WA DFI (2,039 actions, 2001–2026), WI DFI Division of Securities (1,072 actions, 1998–2026), WV Securities Commission (State Auditor) (64 actions), WY Secretary of State Compliance Division (6 actions, 2016–2024) — last crawled Oct 24, 2026, 8:48 AM ET. No machine-readable public listing today for IA, IN, MN, NE, NJ, VA (see docs/state-regulators.md).

3. Bankruptcies

None found in sources searched — federal bankruptcy courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:18 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

25 differences found between the filings for Mina Sooch — 5 worth asking about (compared 31 filings on Oct 24, 2026)

Note · Aug 31, 2010 – Jun 28, 2016

Bankruptcy case: Bernhard U. Hoffmann and Laura K. Hoffmann — filed Aug 31, 2010

United States Bankruptcy Court, E.D. Michigan docket "Bernhard U. Hoffmann and Laura K. Hoffmann" filed Aug 31, 2010, closed Jun 28, 2016. Bernhard Hoffmann (listed on the same filings) is listed as Debtor ("Bernhard U. Hoffmann and Laura K. Hoffmann"). Our match estimate: 70%.

What this means A bankruptcy filing was found. Many are old or personal and have nothing to do with the deal — but ask what it was and when it closed.

Docket · United States Bankruptcy Court, E.D. Michigan ↗Bernhard Hoffmann — PartnerFacts page ↗
Sources
Worth asking · Nov 27, 2009 – Mar 16, 2010

Amount sold went down between filings — SVELTE MEDICAL SYSTEMS INC

The Nov 27, 2009 filing says $6,000,000 sold; the Mar 16, 2010 Form D/A says $4,151,043 sold — $1,848,957 less.

What this means Amounts sold normally only go up as a raise continues. A drop can mean investors were refunded, a figure was corrected, or an earlier number was wrong. Ask the sponsor which it was.

Form D (earlier) · Nov 27, 2009 ↗Form D/A (later) · Mar 16, 2010 ↗SVELTE MEDICAL SYSTEMS INC — PartnerFacts page ↗
Sources
Worth asking · May 28, 2009 – Nov 27, 2009

Amount sold went down between filings — SVELTE MEDICAL SYSTEMS INC

The May 28, 2009 filing says $6,270,000 sold; the Nov 27, 2009 Form D says $6,000,000 sold — $270,000 less.

What this means Amounts sold normally only go up as a raise continues. A drop can mean investors were refunded, a figure was corrected, or an earlier number was wrong. Ask the sponsor which it was.

Form D/A (earlier) · May 28, 2009 ↗Form D (later) · Nov 27, 2009 ↗SVELTE MEDICAL SYSTEMS INC — PartnerFacts page ↗
Sources
Worth asking · May 28, 2009 – Nov 27, 2009

Investor count went down between filings — SVELTE MEDICAL SYSTEMS INC

The May 28, 2009 filing reports 25 investors; the Nov 27, 2009 Form D reports 11 investors.

What this means Investor counts normally only grow. A smaller number can mean investors left or were refunded, or a count was corrected. Ask the sponsor what happened.

Form D/A (earlier) · May 28, 2009 ↗Form D (later) · Nov 27, 2009 ↗SVELTE MEDICAL SYSTEMS INC — PartnerFacts page ↗
Sources
Note · Oct 27, 2010 – Mar 10, 2016

8 filings report more than 10% of the money raised going to insiders

16% of the money raised went to insiders — MetaVia Inc. · 17% of the money raised went to insiders — MetaVia Inc. · 13% of the money raised went to insiders — MetaVia Inc. · 13% of the money raised went to insiders — MetaVia Inc. · 14% of the money raised went to insiders — MetaVia Inc. · and 3 more

What this means The filing reports how much of the money raised was paid to insiders. Over 10% is high for most deals. Ask what it paid for.

Form D/A · Mar 10, 2016 ↗MetaVia Inc. — PartnerFacts page ↗Form D/A · Dec 22, 2015 ↗Form D/A · Aug 7, 2015 ↗
Sources
Worth asking · Nov 19, 2010 – Dec 29, 2020

Mina Sooch appears on 3 deals that stopped filing before reaching their target

SeaStar Medical, Inc. (last filing Dec 29, 2020; $16,439,500 sold of $33,879,000); Ocuphire Pharma, Inc. (last filing Feb 3, 2020; $2,126,253 sold of $10,000,000); APJOHN VENTURES ANNEX FUND, LIMITED PARTNERSHIP (last filing Nov 19, 2010; $1,000,000 sold of $4,000,000). Each has no filing in more than two years and reported under half its target sold.

What this means An issuer whose last filing is more than two years old and reported under half its target sold. The raise may have closed early or quietly stopped. Ask what happened to each.

SeaStar Medical, Inc. — PartnerFacts page ↗Ocuphire Pharma, Inc. — PartnerFacts page ↗APJOHN VENTURES ANNEX FUND, LIMITED PARTNERSHIP — PartnerFacts page ↗
Sources
Worth asking · Nov 1, 2014 – Apr 8, 2015

Form D filed 158 days after the first sale — MetaVia Inc.

The filing says the first sale was Nov 1, 2014. The Form D was filed Apr 8, 2015 — 158 days later. The rule: a Form D is generally due within 15 days after the first sale, so this one is 143 days past that.

What this means A late notice is common and carries no penalty by itself. It is worth asking the sponsor why the paperwork lagged.

Form D · Apr 8, 2015 ↗MetaVia Inc. — PartnerFacts page ↗
Sources
Note · Aug 21, 2008 – Feb 6, 2019

13 offerings have no amendment in the last 12 months and may still be open

No amendment in the last 12 months on an offering that may still be open — Ocuphire Pharma, Inc. (latest filing Feb 6, 2019) · No amendment in the last 12 months on an offering that may still be open — MetaVia Inc. (latest filing Apr 27, 2016) · No amendment in the last 12 months on an offering that may still be open — MetaVia Inc. (latest filing Apr 8, 2015) · No amendment in the last 12 months on an offering that may still be open — ProNAi Therapeutics Inc (latest filing Dec 31, 2013) · No amendment in the last 12 months on an offering that may still be open — SVELTE MEDICAL SYSTEMS INC (latest filing Jun 4, 2013) · and 8 more

What this means SEC rules expect a yearly amendment while an offering is still going. Ask the sponsor which of these raises have closed.

Form D/A · Feb 6, 2019 ↗Ocuphire Pharma, Inc. — PartnerFacts page ↗Form D/A · Apr 27, 2016 ↗MetaVia Inc. — PartnerFacts page ↗
Sources
Note · Apr 15, 2015 – Aug 7, 2015

Mina Sooch's role changed at MetaVia Inc.: executive officer → executive officer, director

The Apr 15, 2015 filing lists Mina Sooch as executive officer; the Aug 7, 2015 Form D/A lists executive officer, director.

What this means Roles on Form D are self-reported by the issuer. A change can mean a real change in who runs the company, or just a different box ticked. Ask who makes decisions today.

Form D · Apr 15, 2015 ↗Form D/A · Aug 7, 2015 ↗Mina Sooch — PartnerFacts page ↗MetaVia Inc. — PartnerFacts page ↗
Sources
Note · Dec 31, 2013 – May 1, 2014

Mina Sooch's role changed at ProNAi Therapeutics Inc: executive officer, director → executive officer

The Dec 31, 2013 filing lists Mina Sooch as executive officer, director; the May 1, 2014 Form D lists executive officer.

What this means Roles on Form D are self-reported by the issuer. A change can mean a real change in who runs the company, or just a different box ticked. Ask who makes decisions today.

Form D · Dec 31, 2013 ↗Form D · May 1, 2014 ↗Mina Sooch — PartnerFacts page ↗ProNAi Therapeutics Inc — PartnerFacts page ↗
Sources
Note · Dec 28, 2010 – Apr 4, 2012

Mina Sooch's role changed at ProNAi Therapeutics Inc: director → executive officer, director

The Dec 28, 2010 filing lists Mina Sooch as director; the Apr 4, 2012 Form D lists executive officer, director.

What this means Roles on Form D are self-reported by the issuer. A change can mean a real change in who runs the company, or just a different box ticked. Ask who makes decisions today.

Form D/A · Dec 28, 2010 ↗Form D · Apr 4, 2012 ↗Mina Sooch — PartnerFacts page ↗ProNAi Therapeutics Inc — PartnerFacts page ↗
Sources
Note · May 28, 2009 – Feb 6, 2019

10 offerings changed their target amount between filings

Offering amount changed between filings — Ocuphire Pharma, Inc. · Offering amount changed between filings — MetaVia Inc. · Offering amount changed between filings — MetaVia Inc. · Offering amount changed between filings — MetaVia Inc. · Offering amount lowered between filings — MetaVia Inc. · and 5 more

What this means Targets change as deals grow or shrink. Ask whether later money has the same terms.

Form D (earlier) · Jun 5, 2018 ↗Form D/A (later) · Feb 6, 2019 ↗Ocuphire Pharma, Inc. — PartnerFacts page ↗Form D/A (earlier) · Mar 10, 2016 ↗
Sources
Note · Jun 5, 2018 – Feb 6, 2019

Minimum investment changed between filings — Ocuphire Pharma, Inc.

The Jun 5, 2018 filing lists a minimum of $5,064; the Feb 6, 2019 Form D/A lists $0.

What this means A different minimum usually means the offering terms changed. Check which terms apply to you.

Form D (earlier) · Jun 5, 2018 ↗Form D/A (later) · Feb 6, 2019 ↗Ocuphire Pharma, Inc. — PartnerFacts page ↗
Sources
Note · Apr 7, 2009 – Dec 28, 2010

Minimum investment changed between filings — ProNAi Therapeutics Inc

The Apr 7, 2009 filing lists a minimum of $10,000; the Dec 28, 2010 Form D/A lists $0.

What this means A different minimum usually means the offering terms changed. Check which terms apply to you.

Form D/A (earlier) · Apr 7, 2009 ↗Form D/A (later) · Dec 28, 2010 ↗ProNAi Therapeutics Inc — PartnerFacts page ↗
Sources
Note · May 28, 2009 – Nov 27, 2009

Minimum investment changed between filings — SVELTE MEDICAL SYSTEMS INC

The May 28, 2009 filing lists a minimum of $6,250; the Nov 27, 2009 Form D lists $0.

What this means A different minimum usually means the offering terms changed. Check which terms apply to you.

Form D/A (earlier) · May 28, 2009 ↗Form D (later) · Nov 27, 2009 ↗SVELTE MEDICAL SYSTEMS INC — PartnerFacts page ↗
Sources
Note · Apr 7, 2009 – Apr 4, 2012

Mina Sooch is written 3 different ways on the filings

listed as "Mina P. Sooch" on 8 filings (from Apr 7, 2009), and "Mina Patel Sooch" on 4 filings (from Nov 6, 2009), and "Mina Sooch" on 19 filings (from Apr 4, 2012).

What this means Same person, written differently — a middle name or suffix left off, or spelled another way. It is normal, but check that the full legal name matches your subscription documents.

Form D/A · Apr 7, 2009 ↗Form D · Nov 6, 2009 ↗Form D · Apr 4, 2012 ↗Mina Sooch — PartnerFacts page ↗
Sources
Note · Apr 8, 2015 – Mar 30, 2017

Industry group changed between filings — MetaVia Inc.

"Biotechnology" (Apr 8, 2015 to Apr 27, 2016); then "Pharmaceuticals" (Mar 30, 2017).

What this means The issuer described its business differently on different forms. Often it is just a different box ticked; sometimes the deal itself changed. Ask which business your money is in.

Form D · Apr 8, 2015 ↗Form D · Mar 30, 2017 ↗MetaVia Inc. — PartnerFacts page ↗
Sources
Note · May 28, 2009 – Jun 21, 2012

Industry group changed between filings — SVELTE MEDICAL SYSTEMS INC

"Biotechnology" (May 28, 2009 to Jul 15, 2011); then "Other Health Care" (Dec 14, 2011); then "Biotechnology" (Jun 21, 2012 to Jun 4, 2013).

What this means The issuer described its business differently on different forms. Often it is just a different box ticked; sometimes the deal itself changed. Ask which business your money is in.

Form D/A · May 28, 2009 ↗Form D · Dec 14, 2011 ↗Form D · Jun 21, 2012 ↗SVELTE MEDICAL SYSTEMS INC — PartnerFacts page ↗
Sources
Note · Nov 6, 2009 – Jun 17, 2010

Industry group changed between filings — SeaStar Medical, Inc.

"Biotechnology" (Nov 6, 2009); then "Other Health Care" (Jun 17, 2010).

What this means The issuer described its business differently on different forms. Often it is just a different box ticked; sometimes the deal itself changed. Ask which business your money is in.

Form D · Nov 6, 2009 ↗Form D · Jun 17, 2010 ↗SeaStar Medical, Inc. — PartnerFacts page ↗
Sources
Note · Apr 8, 2015 – Mar 30, 2017

Reported revenue range changed between filings — MetaVia Inc.

"No Revenues" (Apr 8, 2015); then "Decline to Disclose" (Mar 30, 2017).

What this means This is the size band the issuer picks for itself on the form. A change can mean the business grew or shrank — or that it chose not to say. Ask for current numbers.

Form D · Apr 8, 2015 ↗Form D · Mar 30, 2017 ↗MetaVia Inc. — PartnerFacts page ↗
Sources
Note · Apr 7, 2009 – Dec 28, 2010

Reported revenue range changed between filings — ProNAi Therapeutics Inc

"No Revenues" (Apr 7, 2009); then "Decline to Disclose" (Dec 28, 2010).

What this means This is the size band the issuer picks for itself on the form. A change can mean the business grew or shrank — or that it chose not to say. Ask for current numbers.

Form D/A · Apr 7, 2009 ↗Form D/A · Dec 28, 2010 ↗ProNAi Therapeutics Inc — PartnerFacts page ↗
Sources
Note · May 28, 2009 – Oct 27, 2010

Reported revenue range changed between filings — SVELTE MEDICAL SYSTEMS INC

"Decline to Disclose" (May 28, 2009); then "No Revenues" (Mar 16, 2010); then "$1 - $1,000,000" (Oct 27, 2010).

What this means This is the size band the issuer picks for itself on the form. A change can mean the business grew or shrank — or that it chose not to say. Ask for current numbers.

Form D/A · May 28, 2009 ↗Form D/A · Mar 16, 2010 ↗Form D · Oct 27, 2010 ↗SVELTE MEDICAL SYSTEMS INC — PartnerFacts page ↗
Sources
Note · Jul 10, 2018

Same name, different state: "Mina Sooch" (MA) is a separate record

This page covers filings where the address state is MI or NJ. A separate record, "Mina Sooch" with address state MA, is listed on 1 filing — most recently by BIOVIE INC. (Jul 10, 2018). Both records have filings in the same period (Jul 10, 2018).

What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.

Mina Sooch (MA) — PartnerFacts page ↗Form D · Jul 10, 2018 ↗BIOVIE INC. — PartnerFacts page ↗Mina Sooch (MI,NJ) — this page ↗
Sources
Note · Jun 21, 2012 – Feb 3, 2020

4 address changes between filings

Address moved from West Bloomfield, MI to Farmington Hills, MI — Ocuphire Pharma, Inc. · Address moved from Northville, MI to Livonia, MI — MetaVia Inc. · Address moved from Kalamazoo, MI to Plymouth, MI — ProNAi Therapeutics Inc · Address moved from Kalamazoo, MI to New Providence, NJ — SVELTE MEDICAL SYSTEMS INC

What this means Businesses move. If you were told one city and the forms say another, ask which is current.

Form D/A · Feb 6, 2019 ↗Form D · Feb 3, 2020 ↗Ocuphire Pharma, Inc. — PartnerFacts page ↗Form D/A · Apr 27, 2016 ↗
Sources
Note · Apr 7, 2009 – Nov 20, 2020

Mina Sooch is listed with 2 different address states: MI, NJ

MI on 29 filings (Apr 7, 2009 to Nov 20, 2020); NJ on 2 filings (Apr 29, 2013 to Jun 4, 2013).

What this means The address on a Form D is usually the company's, not the person's home, so this often just reflects different companies. It can also mean a move. Nothing wrong by itself.

Form D/A · Apr 7, 2009 ↗Form D · Apr 29, 2013 ↗
Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.

5. Money to insiders

2 of 20 offerings report sales commissions totalling $2,600,000; 0 report finder's fees; 7 report proceeds to related persons totalling $4,054,709. (includes amounts the issuer reported as estimates)

Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
Nov 20, 2020 D
Opus Genetics, Inc.
File 021-381168
$1,600,000 (est.)$0$0Cantor Fitzgerald & Co. BrokerCheck CRD 134 ↗
Canaccord Genuity LLC BrokerCheck CRD 1020 ↗		EDGAR ↗
Feb 3, 2020 D
Ocuphire Pharma, Inc.
File 021-359570
$0$0$0None listed on this filingEDGAR ↗
Feb 6, 2019 D/A
Ocuphire Pharma, Inc.
File 021-313905
$0 (est.)$0 (est.)$0 (est.)None listed on this filingEDGAR ↗
Apr 24, 2018 D
Ocuphire Pharma, Inc.
File 021-310880
$0 (est.)$0 (est.)$0 (est.)None listed on this filingEDGAR ↗
Mar 30, 2017 D
MetaVia Inc.
File 021-283723
$1,000,000$0$0Piper Jaffray & Co. BrokerCheck CRD 665 ↗
LifeSci Capital LLC BrokerCheck CRD 168404 ↗		EDGAR ↗
Apr 27, 2016 D/A
MetaVia Inc.
File 021-245322
$0$0$900,000 (est.)
The payments listed are for salaries for services to run the business from October 2015 through March 2016. This is not for solicitation and securing the offering.
None listed on this filingEDGAR ↗
Apr 15, 2015 D
MetaVia Inc.
File 021-238001
$0$0$686,900 (est.)
The payments listed are for salaries from April through September 2015 for the Officers and Directors of the Company.
None listed on this filingEDGAR ↗
Apr 8, 2015 D
MetaVia Inc.
File 021-237500
$0$0$513,167
The payments listed are for salaries for services to run the business. This is not for solicitation and securing the offering.
None listed on this filingEDGAR ↗
May 1, 2014 D
ProNAi Therapeutics Inc
File 021-216611
$0$0$0 (est.)None listed on this filingEDGAR ↗
Dec 31, 2013 D
ProNAi Therapeutics Inc
File 021-209007
$0$0$200,000None listed on this filingEDGAR ↗
Jun 4, 2013 D/A
ProNAi Therapeutics Inc
File 021-176136
$0$0$0 (est.)None listed on this filingEDGAR ↗
Jun 4, 2013 D/A
SVELTE MEDICAL SYSTEMS INC
File 021-195730
$0$0$229,642 (est.)None listed on this filingEDGAR ↗
Jun 21, 2012 D
SVELTE MEDICAL SYSTEMS INC
File 021-180116
$0$0$800,000 (est.)None listed on this filingEDGAR ↗
Dec 14, 2011 D
SVELTE MEDICAL SYSTEMS INC
File 021-170051
$0$0$0 (est.)None listed on this filingEDGAR ↗
Jul 15, 2011 D/A
SVELTE MEDICAL SYSTEMS INC
File 021-149681
$0$0$725,000 (est.)None listed on this filingEDGAR ↗
Dec 28, 2010 D/A
ProNAi Therapeutics Inc
File 021-65428
$0$0$0 (est.)None listed on this filingEDGAR ↗
Nov 19, 2010 D
APJOHN VENTURES ANNEX FUND, LIMITED PARTNERSHIP
File 021-150794
$0 (est.)$0 (est.)$0 (est.)None listed on this filingEDGAR ↗
Jun 17, 2010 D
SeaStar Medical, Inc.
File 021-143636
$0$0$0None listed on this filingEDGAR ↗
Mar 16, 2010 D/A
SVELTE MEDICAL SYSTEMS INC
File 021-102229
$0$0$0None listed on this filingEDGAR ↗
Nov 6, 2009 D
SeaStar Medical, Inc.
File 021-110172
$0$0$0None listed on this filingEDGAR ↗
How this is counted

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 7

Every issuer that named Mina Sooch on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

OG
Biotechnology · group: Opus

Opus Genetics, Inc.

Farmington Hills, MI · Nov 20, 2020
  • Nov 20, 2020 · D · $21,150,000 sold of $21,150,000 · 18 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗

Raised $25.8M from 18 investors (100% of the $21.1M target) as of the latest filing. Mina is listed as executive officer, director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

OP
Biotechnology · group: Opus

Ocuphire Pharma, Inc.

Farmington Hills, MI · Apr 24, 2018 → Feb 3, 2020 · 4 filings
  • Feb 3, 2020 · D · $2,126,253 sold of $2,126,253 · 4 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Feb 6, 2019 · D/A · $1,774,460 sold of $10,000,000 · 21 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Jun 5, 2018 · D · $734,460 sold of $5,000,000 · 8 investors · min. $5,064 · role: Executive Officer, Director EDGAR ↗
  • Apr 24, 2018 · D · $17,000 sold of $17,000 · 72 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗

Raised $2.13M from 72 investors (100% of the $2.13M target) as of the latest filing. Mina is listed as executive officer, director on 4 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

M
Pharmaceuticals

MetaVia Inc.

Cambridge, MA · Apr 8, 2015 → Mar 30, 2017 · 8 filings
  • Mar 30, 2017 · D · $12,540,704 sold of $12,540,704 · 26 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Apr 27, 2016 · D/A · $10,601,500 sold of $14,000,000 · 59 investors · min. $10,000 · role: Executive Officer, Director EDGAR ↗
  • Mar 10, 2016 · D/A · $5,601,500 sold of $9,000,000 · 53 investors · min. $10,000 · role: Executive Officer, Director EDGAR ↗
  • Dec 22, 2015 · D/A · $5,451,000 sold of $5,451,000 · 52 investors · min. $10,000 · role: Executive Officer, Director EDGAR ↗
  • Aug 7, 2015 · D/A · $2,801,000 sold of $2,801,000 · 36 investors · min. $10,000 · role: Executive Officer, Director EDGAR ↗
  • Aug 7, 2015 · D · $2,801,000 sold of $3,000,000 · 36 investors · min. $10,000 · role: Executive Officer, Director EDGAR ↗
  • Apr 15, 2015 · D · $5,000,000 sold of $5,000,000 · 46 investors · min. $10,000 · role: Executive Officer EDGAR ↗
  • Apr 8, 2015 · D · $2,739,049 sold of $3,000,000 · 28 investors · min. $15,000 · role: Executive Officer EDGAR ↗

Raised $17M from 59 investors (100% of the $12.5M target) as of the latest filing. Mina is listed as executive officer, director on 8 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

PT
Biotechnology

ProNAi Therapeutics Inc

Plymouth, MI · Apr 7, 2009 → May 1, 2014 · 6 filings
  • May 1, 2014 · D · $59,500,000 sold of $59,500,000 · 57 investors · min. No minimum reported · role: Executive Officer EDGAR ↗
  • Dec 31, 2013 · D · $11,176,453 sold of $17,797,953 · 45 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Jun 4, 2013 · D/A · $4,300,993 sold of $5,000,000 · 37 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Apr 4, 2012 · D · $310,000 sold of $1,000,000 · 13 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Dec 28, 2010 · D/A · $1,691,410 sold of $12,000,000 · 16 investors · min. No minimum reported · role: Director EDGAR ↗
  • Apr 7, 2009 · D/A · $685,130 sold of $12,000,000 · 9 investors · min. $10,000 · role: Director EDGAR ↗

Raised $59.5M from 57 investors (100% of the $59.5M target) as of the latest filing. Mina is listed as executive officer, director on 6 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

SM
Biotechnology

SVELTE MEDICAL SYSTEMS INC

New Providence, NJ · May 28, 2009 → Jun 4, 2013 · 9 filings
  • Jun 4, 2013 · D/A · $4,307,884 sold of $5,470,329 · 7 investors · min. No minimum reported · role: Director EDGAR ↗
  • Apr 29, 2013 · D · $1,809,555 sold of $3,000,000 · 3 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jun 21, 2012 · D · $5,000,000 sold of $7,000,000 · 13 investors · min. No minimum reported · role: Director EDGAR ↗
  • Dec 14, 2011 · D · $18,784,666 sold of $35,000,000 · 22 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jul 15, 2011 · D/A · $9,694,400 sold of $12,000,000 · 22 investors · min. No minimum reported · role: Director EDGAR ↗
  • Oct 27, 2010 · D · $4,492,700 sold of $6,000,000 · 14 investors · min. No minimum reported · role: Director EDGAR ↗
  • Mar 16, 2010 · D/A · $4,151,043 sold of $10,000,000 · 22 investors · min. No minimum reported · role: Director EDGAR ↗
  • Nov 27, 2009 · D · $6,000,000 sold of $9,000,000 · 11 investors · min. No minimum reported · role: Director EDGAR ↗
  • May 28, 2009 · D/A · $6,270,000 sold of $8,000,000 · 25 investors · min. $6,250 · role: Director EDGAR ↗

Raised $50.4M from 39 investors (100% of the $5.47M target) as of the latest filing. Mina is listed as director on 9 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

AV
Pooled Investment Fund · group: Group linked by Donald R. Parfet

APJOHN VENTURES ANNEX FUND, LIMITED PARTNERSHIP

Kalamazoo, MI · Nov 19, 2010
  • Nov 19, 2010 · D · $1,000,000 sold of $4,000,000 · 12 investors · min. $50,000 · role: Executive Officer, Promoter (MANAGER OF GENERAL PARTNER) EDGAR ↗

Raised $1M from 12 investors (25% of the $4M target) as of the latest filing. Mina is listed as executive officer, promoter.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

SM
Other Health Care · group: Seastar Medical

SeaStar Medical, Inc.

Denver, CO · Nov 6, 2009 → Jun 17, 2010 · 2 filings
  • Jun 17, 2010 · D · $11,686,876 sold of $12,000,000 · 5 investors · min. $250,000 · role: Director EDGAR ↗
  • Nov 6, 2009 · D · $2,000,000 sold of $2,000,000 · 5 investors · min. $235,294 · role: Director EDGAR ↗

Raised $16.4M from 23 investors (100% of the $12M target) as of the latest filing. Mina is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

Other pages with the same name (1)

Separate person records under the same name, not combined with this page. Each line says whether it shares an issuer with this record.

  • Mina Sooch — MA, 1 issuer, Jul 10, 2018 → Jul 10, 2018 · no shared issuer

People around Mina 40

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET. Showing the 40 with the most shared filings.

CB
No photo found yet (own website and image search run after this page is viewed)
Person

Charles Bisgaier

Director, Executive Officer · 13 shared filings (2 issuers) · also on 1 other issuer

Listed on the same filings as Mina Sooch. Their page shows their other deals.

MP
No photo found yet (own website and image search run after this page is viewed)
Person

Mark Pomeranz

Executive Officer, Director · 9 shared filings (1 issuer)

Listed on the same filings as Mina Sooch. Their page shows their other deals.

PT
No photo found yet (own website and image search run after this page is viewed)
Person

Phillip D. Torrence

Executive Officer · 9 shared filings (1 issuer) · also on 4 other issuers

Phillip D. Torrence is on 5 issuers in total — a repeat sponsor. Their page lists every one.

TF
No photo found yet (own website and image search run after this page is viewed)
Person

Tim A. Fischell

Executive Officer, Director · 9 shared filings (1 issuer) · also on 4 other issuers

Tim A. Fischell is on 5 issuers in total — a repeat sponsor. Their page lists every one.

RF
No photo found yet (own website and image search run after this page is viewed)
Person

Robert E. Fischell

Executive Officer, Director · 9 shared filings (1 issuer) · also on 7 other issuers

Robert E. Fischell is on 8 issuers in total — a repeat sponsor. Their page lists every one.

DF
No photo found yet (own website and image search run after this page is viewed)
Person

David R. Fischell

Executive Officer, Director · 9 shared filings (1 issuer) · also on 7 other issuers

David R. Fischell is on 8 issuers in total — a repeat sponsor. Their page lists every one.

RF
No photo found yet (own website and image search run after this page is viewed)
Person

Robert Flanagan

Director · 9 shared filings (1 issuer) · also on 3 other issuers

Listed on the same filings as Mina Sooch. Their page shows their other deals.

MK
No photo found yet (own website and image search run after this page is viewed)
Person

Mark A. Kielek

Executive Officer · 8 shared filings (1 issuer)

Listed on the same filings as Mina Sooch. Their page shows their other deals.

PH
No photo found yet (own website and image search run after this page is viewed)
Person

P. Kent Hawryluk

Director · 8 shared filings (1 issuer)

Listed on the same filings as Mina Sooch. Their page shows their other deals.

RC
No photo found yet (own website and image search run after this page is viewed)
Person

Robert W. Croce

Director · 7 shared filings (1 issuer) · also on 11 other issuers

Robert W. Croce is on 12 issuers in total — a repeat sponsor. Their page lists every one.

DP
No photo found yet (own website and image search run after this page is viewed)
Person

Donald R. Parfet

Director, Executive Officer, Promoter · 7 shared filings (2 issuers) · also on 8 other issuers

Donald R. Parfet is on 10 issuers in total — a repeat sponsor. Their page lists every one.

KK
No photo found yet (own website and image search run after this page is viewed)
Person

Kenneth Kousky

Director · 7 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Mina Sooch. Their page shows their other deals.

DL
No photo found yet (own website and image search run after this page is viewed)
Person

David Lowenschuss

Executive Officer, Director · 7 shared filings (1 issuer)

Listed on the same filings as Mina Sooch. Their page shows their other deals.

MM
No photo found yet (own website and image search run after this page is viewed)
Person

Margaret McShane

Executive Officer · 7 shared filings (1 issuer)

Listed on the same filings as Mina Sooch. Their page shows their other deals.

DO
No photo found yet (own website and image search run after this page is viewed)
Person

Daniela Oniciu

Executive Officer · 7 shared filings (1 issuer)

Listed on the same filings as Mina Sooch. Their page shows their other deals.

AS
No photo found yet (own website and image search run after this page is viewed)
Person

Andy Sassine

Director · 6 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Mina Sooch. Their page shows their other deals.

DB
No photo found yet (own website and image search run after this page is viewed)
Person

Dan Bowen

Director · 5 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Mina Sooch. Their page shows their other deals.

SB
No photo found yet (own website and image search run after this page is viewed)
Person

Steve Burpee

Director · 5 shared filings (1 issuer)

Listed on the same filings as Mina Sooch. Their page shows their other deals.

JL
No photo found yet (own website and image search run after this page is viewed)
Person

Jack Luderer

Director · 5 shared filings (1 issuer)

Listed on the same filings as Mina Sooch. Their page shows their other deals.

MJ
No photo found yet (own website and image search run after this page is viewed)
Person

Michael Johnson

Executive Officer · 5 shared filings (1 issuer)

Listed on the same filings as Mina Sooch. Their page shows their other deals.

RF
No photo found yet (own website and image search run after this page is viewed)
Person

Robert Forgey

Executive Officer, Director · 4 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Mina Sooch. Their page shows their other deals.

PL
No photo found yet (own website and image search run after this page is viewed)
Person

Pedro Lichtinger

Director · 4 shared filings (1 issuer) · also on 3 other issuers

Listed on the same filings as Mina Sooch. Their page shows their other deals.

SA
No photo found yet (own website and image search run after this page is viewed)
Person

Sean Ainsworth

Director · 4 shared filings (2 issuers) · also on 1 other issuer

Listed on the same filings as Mina Sooch. Their page shows their other deals.

WR
No photo found yet (own website and image search run after this page is viewed)
Person

Wendi Rodrigueza

Executive Officer · 4 shared filings (1 issuer)

Listed on the same filings as Mina Sooch. Their page shows their other deals.

JM
No photo found yet (own website and image search run after this page is viewed)
Person

Jeffrey Mathiesen

Executive Officer · 4 shared filings (1 issuer)

Listed on the same filings as Mina Sooch. Their page shows their other deals.

SR
No photo found yet (own website and image search run after this page is viewed)
Person

Seth Reno

Executive Officer · 4 shared filings (1 issuer)

Listed on the same filings as Mina Sooch. Their page shows their other deals.

AM
No photo found yet (own website and image search run after this page is viewed)
Person

Alan Meyer

Director · 4 shared filings (2 issuers)

Listed on the same filings as Mina Sooch. Their page shows their other deals.

RM
No photo found yet (own website and image search run after this page is viewed)
Person

Richard Messmann

Executive Officer · 3 shared filings (1 issuer)

Listed on the same filings as Mina Sooch. Their page shows their other deals.

RS
No photo found yet (own website and image search run after this page is viewed)
Person

Richard T. Spencer

Executive Officer · 3 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Mina Sooch. Their page shows their other deals.

AR
No photo found yet (own website and image search run after this page is viewed)
Person

Amy Zaremba Rabourn

Director, Executive Officer · 3 shared filings (2 issuers)

Listed on the same filings as Mina Sooch. Their page shows their other deals.

HH
No photo found yet (own website and image search run after this page is viewed)
Person

H. David Humes

Director · 2 shared filings (1 issuer)

Listed on the same filings as Mina Sooch. Their page shows their other deals.

RD
No photo found yet (own website and image search run after this page is viewed)
Person

R. James Danehy

Executive Officer, Director · 2 shared filings (1 issuer)

Listed on the same filings as Mina Sooch. Their page shows their other deals.

MM
No photo found yet (own website and image search run after this page is viewed)
Person

Mark R. Morsfield

Executive Officer · 2 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Mina Sooch. Their page shows their other deals.

SG
No photo found yet (own website and image search run after this page is viewed)
Person

Steve Gullans

Director · 2 shared filings (1 issuer) · also on 3 other issuers

Listed on the same filings as Mina Sooch. Their page shows their other deals.

AV
No photo found yet (own website and image search run after this page is viewed)
Person

Alvin Vitangcol

Director · 2 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Mina Sooch. Their page shows their other deals.

JP
No photo found yet (own website and image search run after this page is viewed)
Person

John Puisus

Director · 2 shared filings (1 issuer)

Listed on the same filings as Mina Sooch. Their page shows their other deals.

JD
No photo found yet (own website and image search run after this page is viewed)
Person

Jack Darby

Executive Officer, Director · 2 shared filings (1 issuer)

Listed on the same filings as Mina Sooch. Their page shows their other deals.

CG
No photo found yet (own website and image search run after this page is viewed)
Person

Cam Gallagher

Director · 2 shared filings (2 issuers) · also on 1 other issuer

Listed on the same filings as Mina Sooch. Their page shows their other deals.

BH
No photo found yet (own website and image search run after this page is viewed)
Person

Bernhard Hoffmann

Executive Officer · 2 shared filings (2 issuers)

Listed on the same filings as Mina Sooch. Their page shows their other deals.

The team behind the deals

O
Sponsor group

Opus

2 issuers · 6 filings · $27.9M reported sold · 2018–2024

One team, 2 deal companies. Mina Sooch is listed on 2 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Mina Sooch.

SM
Sponsor group

Seastar Medical

2 issuers · 6 filings · $8.57M reported sold · 2009–2026

One team, 2 deal companies. Mina Sooch is listed on 1 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Mina Sooch.

GL
Sponsor group

Group linked by Donald R. Parfet

6 issuers · 26 filings · $5.47M reported sold · 2009–2017

One team, 6 deal companies. Mina Sooch is listed on 1 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Mina Sooch.

Same business address

19 other issuers file from the same address

A shared address can mean the same team, a shared office building or a registered agent. It is a lead, not a conclusion.

Registrations and other filings

Business registration (state registry / Secretary of State)

Individuals are not matched to business registrations — registries list companies, and a name alone is not enough to tie a person to one. Officers and managers appear by name inside each matched company's record on the issuer pages. Registries searched: AL (Alabama Secretary of State — Business Entity Records (arc-sos.state.al.us), searched by issuer name, data as of Oct 24, 2026); CO (Colorado Secretary of State — Business Entities in Colorado (data.colorado.gov), data as of Oct 23, 2026); CT (Connecticut Secretary of the State — Business Registry (data.ct.gov), data as of Oct 24, 2026); FL (Florida Department of State, Division of Corporations — quarterly corporate data file (Sunbiz), data as of Oct 7, 2026); NY (New York Department of State — Corporations and Other Entities (data.ny.gov: All Filings + Active Corporations), data as of Oct 20, 2026); OR (Oregon Secretary of State — Active Businesses, All (data.oregon.gov), data as of Oct 20, 2026); PA (Pennsylvania Department of State — Registered Businesses, Current (data.pa.gov), data as of Oct 6, 2026); TX (Texas Comptroller — Active Franchise Taxpayers incl. Secretary of State file data (data.texas.gov), data as of Oct 24, 2026). Registries of other states have not been searched: many publish no bulk file and require a CAPTCHA or bot challenge on their search page, which we do not bypass (Delaware, for example, offers no public bulk file).

Adviser registration (Form ADV)

None of the 7 issuers this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Property records none — individuals are not matched

Property records are matched to companies only, never to individuals, so none are matched to Mina Sooch by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 7 issuers this person is listed on — nothing matched.

Public profiles and social

Websites and social links of the issuers Mina Sooch is listed on: none on file. No website or social profile named in Opus Genetics, Inc.'s SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #85,964 of 374,652 in line (1,386 issuers searched so far). One-tap searches: Look further ↓

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (Farmington Hills, MI). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Social and web

LinkedIn people search ↗Instagram ↗X (Twitter) ↗Facebook ↗YouTube ↗Google ↗Google Images ↗Google News ↗Meta Ad Library ↗

Courts

CourtListener / RECAP (federal) ↗PACER case locator (federal, login) ↗Michigan state courts — find the court ↗New Jersey state courts — find the court ↗Colorado state courts — find the court ↗Massachusetts MassCourts ↗

Securities regulators

SEC EDGAR full-text search ↗SEC action look-up ↗FINRA BrokerCheck ↗SEC IAPD adviser search ↗

Business registries

Michigan Secretary of State business search ↗New Jersey Secretary of State business search ↗Colorado Secretary of State business search ↗Massachusetts Secretary of State business search ↗OpenCorporates ↗

Change history

No corrections have been requested for this page.

Every fact links to its public-record source. Plain-English notes next to a fact are our reading of that fact, not a rating. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when Mina Sooch appears on a new Form D, or when a court case or SEC action is matched to them. See plans →